Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to Disease Activity Score-28

References

• Itoh M, Takahashi T, Sakaguchi N, . Thymus and autoimmunity production of CD25+CD4+ naturally anergic and suppressive T-cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol. 1999; 162:5317–5322.
   PubMed Web of Science ®Google Scholar
• Chai J, Bartok J, Chandler P, . Anergic T-cells act as suppressor cells in vitro and in vivo. Eur J Immunol. 1999; 29:686–692.
   PubMed Web of Science ®Google Scholar
• Read S, Powrie F. CD4+ regulatory T-cells. Curr Opin Immunol. 2001; 13:644–649.
   PubMed Web of Science ®Google Scholar
• Shevach E. Certified professionals. CD4+CD25+ suppressor T-cells. J Exp Med. 2001; 193:41–45.
   PubMed Web of Science ®Google Scholar
• Maloy J, Powrie F. Regulatory T-cells in the control of immune pathology. Nat Immunol. 2001; 2:816–822.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T-cells expressing IL-2 receptor alpha chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995; 155:1151–1164.
   PubMed Web of Science ®Google Scholar
• Stephens L, Mottet C, Mason D, Powrie F. Human CD4+CD25+ thymocytes and peripheral T-cells have immunosuppressive activity in vitro. Eur J Immunol. 2001; 31:1247–1254.
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk A. Identification and functional characterization of human CD4+CD25+ T-cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001; 193:1285–1294.
   PubMed Web of Science ®Google Scholar
• Lan RY, Ansari AA, Lian Z-X, Gershwin ME. Regulatory T cells: Development, function and role in autoimmunity. Autoimmun Rev. 2005; 4:351–363.
   PubMed Web of Science ®Google Scholar
• Bach F. Regulatory T cells under scrutiny. Nat Rev Immunol. 2003; 3:189–198.
   PubMed Web of Science ®Google Scholar
• Salomon B, Lenschow D, Rhee L, . B7/CD28 co-stimulation is essential for the homeostasis of CD4+CD25+ immunoregulatory T-cells that control autoimmune diabetes. Immunity. 2000; 12:431–440.
   PubMed Web of Science ®Google Scholar
• Akbar A, Taams L, Salmon M, Vurmanovic-Stejic M. The peripheral generation of CD4+CD25+ regulatory T-cells. Immunology. 2003; 109:319–325.
   PubMed Web of Science ®Google Scholar
• Thornton A, Piccirillo CA, Shevach E. Activation requirements for the induction of CD4+CD25+ T-cell suppressor function. Eur J Immunol. 2004; 34:366–376.
   PubMed Web of Science ®Google Scholar
• Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003 May 15; 423:356–361.
   PubMed Web of Science ®Google Scholar
• Lawson CA, Brown AK, Bejarano V, . Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. Rheumatology. 2006; 45:1210–1217.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004; 22:531–562.
   PubMed Web of Science ®Google Scholar
• Kataoka H, Takahashi K, Takase S, . CD25+CD4+ regulatory T-cells exert in vitro suppressive activity independent of CTLA-4. Int Immunol. 2005; 17:421–427.
   PubMed Web of Science ®Google Scholar
• Fontenot J, Gavin M, Rudensky A. Foxp3 programs the development and function of CD4+CD25+ regulatory T-cells. Nat Immunol. 2003; 4:330–336.
   PubMed Web of Science ®Google Scholar
• Yi H, Zhen Y, Jiang L, Zheng J, Zhao Y. The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells. Cell Mol Immunol. 2006; 3:189–195.
   PubMed Web of Science ®Google Scholar
• Liu H, Leung BP. CD4+CD25+ regulatory T cells in health and disease. Clin Exp Pharmacol Physiol. 2006; 33:519–524.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Fox DA. Regulatory T cell defects in rheumatoid arthritis. Arthritis Rheum. 2007; 56:710–713.
   PubMedGoogle Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299:1057–1061.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005; 6:345–352.
   PubMed Web of Science ®Google Scholar
• Leipe J, Skapenko A, Lipsky PE, Schulze-Koops H. Regulatory T cells in rheumatoid arthritis. Arthritis Res Ther. 2005; 7:93–99.
   PubMed Web of Science ®Google Scholar
• Levings M, Roncarolo M. Phenotypic and functional differences between human CD4+CD25+ and type 1 regulatory T-cells. Curr Top Microbiol Immunol. 2005; 293:303–326.
   PubMed Web of Science ®Google Scholar
• Weiner H. Oral tolerance: immune mechanisms and the generation of Th3-type TGFα-secreting regulatory cells. Microbes Infect. 2001; 3:947–954.
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 1992; 35:498–502.
   PubMed Web of Science ®Google Scholar
• Lyssuk EY, Torgashina AV, Soloviev SK, Nassonov EL, Bykovskaia SN. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol. 2007; 601:113–119.
   PubMed Web of Science ®Google Scholar
• Bonelli M, von Dalwigk K, Savistskaya A, Smolen JS, Scheinecker C. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus (SLE): a comparative phenotype analysis. Ann Rheum Dis. 2008; 67:664–671.
   PubMed Web of Science ®Google Scholar
• Barath S, Soltész P, Kiss E, . The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4(+)CD25(high)FoxP3(+) regulatory T cells during repeated plasmapheresis treatments of patients. Autoimmunity. 2007; 40:521–528.
   PubMed Web of Science ®Google Scholar
• Banica L, Besliu A, Pistol G, . Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity. 2009; 42:41–49.
   PubMed Web of Science ®Google Scholar
• Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4+ T-cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol. 2003; 33:215–223.
   PubMed Web of Science ®Google Scholar
• Liu MF, Wang CR, Fung LL, Wu CR. Decreased CD4+CD25+ T-cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol. 2004; 59:198–202.
   PubMed Web of Science ®Google Scholar
• Möttönen M, Heikkinen J, Mustonen L, Isomaki P, Luukkainen R, Lassila O. CD4+ CD25+ T-cells with the phenotypic and functional characteristics of regulatory T-cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol. 2005; 140:360–367.
   PubMed Web of Science ®Google Scholar
• van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS. CD4+CD25+ regulatory T cells in rheumatoid arthritis. Differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004; 50:2775–2785.
   PubMed Web of Science ®Google Scholar
• Cao D, van Vollenhoven R, Klareskog L, Trollmo C, Malmstrom V. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther. 2004; 6:335–346.
   PubMed Web of Science ®Google Scholar
• Kao JK, Hsue YT, Lin CH. Role of new population of peripheral CD11c+CD8+ T-cells and CD4+CD25+ regulatory T-cells during acute and remission stages in rheumatoid arthritis patients. J Microbiol Immunol Infect. 2007; 40:419–427.
   PubMedGoogle Scholar
• Ehrenstein MR, Evans JG, Singh A, . Compromised function of regulatory T-cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med. 2004; 200:277–285.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Rudensky A. FoxP3 in control of the regulatory T-cell lineage. Nat Immunol. 2007; 8:457–462.
   PubMed Web of Science ®Google Scholar
• Campbell DJ, Ziegler S. FoxP3 modifies the phenotypic and functional properties of regulatory T-cells. Nat Rev. 2007; 7:305–310.
   Google Scholar
• Ziegler SF. FoxP3: Of mice and men. Annu Rev Immunol. 2006; 24:209–226.
   PubMed Web of Science ®Google Scholar
• Ziegler SF. FoxP3: Not just for regulatory T cells anymore. Eur J Immunol. 2007; 37:21–23.
   PubMed Web of Science ®Google Scholar
• Allan SE, Crome SQ, Crellin NK, . Activation-induced FoxP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol. 2007; 19:345–354.
   PubMed Web of Science ®Google Scholar
• Lepault F, Gagnerault M. Characterization of peripheral regulatory CD4+ T-cells that prevent diabetes onset in nonobese diabetic mice. J Immunol. 2000; 164:240–247.
   PubMed Web of Science ®Google Scholar
• Ng WF, Duggan J, Ponchel F, . Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells. Blood. 2001; 98:2736–2744.
   PubMed Web of Science ®Google Scholar
• Cosme L, Liotta F, Lazzeri E, . Human CD8+CD25+ thymocytes sharing phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood. 2003; 102:4107–4114.
   PubMed Web of Science ®Google Scholar
• Joosten SA, van Meijgarden KE, Savage NDL, . Identification of human CD8+ regulatory T-cell subset that mediates suppression through the chemokine CC chemokine ligand 4. PNAS. 2007; 104:8029–8034.
   PubMed Web of Science ®Google Scholar
• Meloni F, Morosini M, Solari N, . FoxP3 expressing CD4+CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum Immunol. 2006; 67:1–12.
   PubMed Web of Science ®Google Scholar
• Brisslert M, Bokarewa M, Larsson P, Wing K, Vincent Collins L, Tarkowski A. Phenotypic and functional characterization of human CD25+B cells. Immunology. 2006; 117:548–557.
   PubMed Web of Science ®Google Scholar
• Morita Y, Yamamura M, Kawashima M, . Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with Rheumatoid arthritis. Arthritis Rheum. 1998; 41:1669–1676.
   PubMed Web of Science ®Google Scholar
• Belghith M, Bluestone JA, Barriot S, Megret J, Bach JF, Chatenoud L. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med. 2003; 9:1202–1208.
   PubMed Web of Science ®Google Scholar
• Pyzik M, Piccirillo CA. TGF-β1 modulates FoxP3 expression and regulatory activity in distinct CD4+ T-cell subsets. J Leukocyte Biol. 2007; 82:1–11.
   PubMed Web of Science ®Google Scholar
• Zheng SG, Wang JH, Stohl W, Kim KS, Gray JD, Horwitz DA. TGF-b requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ Regulatory cells. J Immunol. 2006; 176:3321–3329.
   PubMed Web of Science ®Google Scholar
• Suárez A, López P, Gómez J, Gutierrez C. Enrichment of CD4+CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis. 2006; 65:1512–1517.
   PubMed Web of Science ®Google Scholar